HealthWHO Approves Newborn-Specific Malaria Drug to Reduce Infant Deaths
The World Health Organization has prequalified a new malaria drug formulation specifically for newborns weighing two to five kilograms, aiming to reduce early-life malaria deaths in Africa, especially Nigeria. Experts highlight its potential to improve dosing safety and effectiveness, addressing a critical treatment gap. Nigerian health leaders call for affordable access, professional training, and ongoing safety monitoring to maximize impact.
Brand Icon Image - Latest Brand, Tech And Business··Lagos




